Baird Medical Investment Holdings (BDMD) Current Deferred Revenue (2023 - 2026)

Baird Medical Investment Holdings (BDMD) has reported Current Deferred Revenue for 4 consecutive years, with $2.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Deferred Revenue rose 123.51% year-over-year to $2.4 million in Q2 2026; TTM through Jun 2026 was $2.4 million, a 123.51% increase from a year earlier, with the FY2025 full-year figure at $793412.0, changed 0.17% from the prior year.
• Current Deferred Revenue was $2.4 million for Q2 2026 at Baird Medical Investment Holdings, up from $793412.0 in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $2.4 million in Q2 2026 and troughed at $200000.0 in Q4 2023.
• A 4-year average of $1.1 million and a median of $793412.0 in 2025 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue jumped 296.05% in 2024 and rose 0.17% in 2025, its largest moves.
• Over 4 years, Current Deferred Revenue stood at $200000.0 in 2023, then jumped by 296.05% to $792102.0 in 2024, then grew by 0.17% to $793412.0 in 2025, then surged by 208.03% to $2.4 million in 2026.
• The last three Current Deferred Revenue figures came in at $2.4 million (Q2 2026), $793412.0 (Q4 2025), and $1.1 million (Q2 2025), per Business Quant data.